Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New tryptase inhibitors from Bayer useful for allergic disorders

May 18, 2000

Schering-Plough presents new humanized anti-IL-5 MAbs for asthma

May 18, 2000

Bronchodilating PDE4 inhibitors synthesized and tested by Dainippon

May 17, 2000

Orphan drug status granted for Merrem I.V. as cystic fibrosis treatment

May 17, 2000

Tiotropium bromide produces long-lasting bronchodilatation in patients with COPD

May 16, 2000

Naphthalenecarboxamide-based tachykinin antagonists in development by AstraZeneca

May 15, 2000

Bayer presents new PDE inhibitor in development for COPD and asthma

May 12, 2000

ISOLDE trial results support use of inhaled corticosteroids in COPD

May 12, 2000

FDA approves Cafcit oral solution for treatment of AOP

May 12, 2000

Multiple mechanisms of action endow new compound with potent activity in models of COPD and asthma

May 11, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...